We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The British High Commission in Windhoek partnered with other Diplomatic Missions' resident in Namibia, to support the Bank Windhoek Cancer Apple Project.
Additional vaccines will help ensure the UK can protect those that may be at high risk from mpox
Paul Corrigan brings extensive sector experience and will work on emerging policy to support the government on successfully delivering better health services.
Men taking valproate and their partners are being advised by the Medicines and Healthcare products Regulatory Agency (MHRA) to use effective contraception because of new data suggesting a potential small increased risk of ha…
Legislation has been laid in Parliament to ban xylazine and 21 other dangerous drugs.
As the new school year looms, the MHRA sets out key advice on children's medicines and medical devices.
More than 130,000 people across the country will be better protected from diseases such as heart disease, kidney disease and diabetes.
The measles vaccination is part of the NHS Routine Childhood Immunisation Programme – with 1 dose offered at 1 year and a second dose at 3 years 4 months.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 22 August 2024, approved a product licence for the medicine lecanemab (Leqembi) for use in the early stages of Alzheimer’s disease, following a thorou…
Temporary ban on prescription and supply of puberty blockers extended.
The UK Health Security Agency is encouraging students to make the healthiest start to their studies possible.
The UK Health Security Agency responds to the World Health Organisation declaring an mpox outbreak a public health emergency of international concern.
Between June 2022 and May 2024, 15 ceftriaxone-resistant gonorrhoea cases were detected in England
Health and Social Care Secretary Wes Streeting responds to the Care Quality Commission's (CQC) report outlining failings in Valdo Calocane's care.
Study shows new RSV vaccine for pregnant women could prevent 5,000 hospitalisations and 15,000 emergency department attendances for infants.
UKHSA urges pregnant women to get vaccinated to protect their newborn babies as whooping cough cases rise to over 10,000
JCVI advises government on the COVID-19 vaccination programme for autumn 2024
Minister Andrew Gwynne has accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI).
A national respiratory syncytial virus (RSV) vaccine programme protecting infants and elderly people will save lives in the UK.
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).